Medical Device Innovation Consortium (MDIC), through its public-private partnership, aims to accelerate and improve patient access to innovative, high-quality, safe, and cost-effective medical technologies.
Members of MDIC share a vision of a world with timely access to safe and cost-effective medical innovations to improve patients’ lives.
Our board includes the director of CDRH, the director of Coverage and Analysis at CMS, executives representing patient organizations, non-profits, and industry.
MDIC is the first-ever public-private partnership (PPP) created with the sole objective of advancing medical device regulatory science.
We are a nonprofit 501(c)3 organization that operates in partnership with the FDA to improve the medical technology environment.
Participation in MDIC is open to representatives of organizations that are substantially involved in medical and/or medical device:
Our members are also involved in the promotion of public health or have expertise in regulatory science.
MDIC works on science, not policy.
Our work improves patient access and safety while reducing costs to the healthcare system. We work on what is essential to all stakeholders. We are helping to re-engineer the tools for innovation and regulatory assessments to address the unsustainable cost trajectory of medical technology innovation